Prof. Dr. Murat EMRE

NEUROPSYCHIATRIC AND COGNITIVE CHANGES IN PARKINSON'S DISEASE AND RELATED MOVEMENT DISORDERS: DIAGNOSIS AND MANAGEMENT , ss.177-191, 2013 (SCI-Expanded)

20. The ABC of Ataxia Should Also Include the E

Hanagasi H. A., Emre M.

MOVEMENT DISORDERS: UNFORGETTABLE CASES AND LESSONS FROM THE BEDSIDE , ss.238-239, 2013 (SCI-Expanded)

21. Neuroimaging, biomarkers, and management of dementia with Lewy bodies

Hanagasi H. A., Bilgic B., Emre M.

FRONTIERS IN NEUROLOGY , cilt.4, 2013 (SCI-Expanded)

22. Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study

Dubois B., Tolosa E., Katzenschlager R., Emre M., Lees A. J., Schumann G., et al.

MOVEMENT DISORDERS , cilt.27, sa.10, ss.1230-1238, 2012 (SCI-Expanded)

23. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Litvan I., Goldman J. G., Troester A. I., Schmand B. A., Weintraub D., Petersen R. C., et al.

MOVEMENT DISORDERS , cilt.27, sa.3, ss.349-356, 2012 (SCI-Expanded)

24. Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone

Reichmann H., Emre M.

EXPERT REVIEW OF NEUROTHERAPEUTICS , cilt.12, sa.2, ss.119-131, 2012 (SCI-Expanded)

25. The Impact of Familial Structure on Parkinson's Disease in Istanbul Medical School, Turkey

Lohmann E., Hanagasi H. A., Gurvit H., Kayaci G., Ruberg M., Yazici J., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.122, sa.2, ss.102-105, 2012 (SCI-Expanded)

26. Perampanel in Parkinson Disease Fluctuations: A Double-Blind Randomized Trial With Placebo and Entacapone

Rascol O., Barone P., Behari M., Emre M., Giladi N., Olanow C. W., et al.

CLINICAL NEUROPHARMACOLOGY , cilt.35, sa.1, ss.15-20, 2012 (SCI-Expanded)

27. Cognitive impairment in nondemented Parkinson's disease

Barone P., Aarsland D., Burn D., Emre M., Kulisevsky J., Weintraub D.

MOVEMENT DISORDERS , cilt.26, sa.14, ss.2483-2495, 2011 (SCI-Expanded)

28. Mild cognitive impairment and cognitive reserve in Parkinson's disease

Poletti M., Emre M., Bonuccelli U.

PARKINSONISM & RELATED DISORDERS , cilt.17, sa.8, ss.579-586, 2011 (SCI-Expanded)

29. Cognitive Correlates of Visual Hallucinations in Dementia Associated with Parkinson's Disease

Bronnick K., Emre M., Tekin S., Haugen S. B., Aarsland D.

MOVEMENT DISORDERS , cilt.26, sa.5, ss.824-829, 2011 (SCI-Expanded)

30. Crossed Aphasia in a Dextral Patient With Logopenic/Phonological Variant of Primary Progressive Aphasia

DEMIRTAS-TATLIDEDE A., Gurvit H., OKTEM-TANOR O., Emre M.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.23, sa.2, ss.6-7, 2011 (SCI-Expanded)

31. Pain is common in Parkinson's disease

HANAGASI H. A., AKAT S., Gurvit H., Yazici J., Emre M.

CLINICAL NEUROLOGY AND NEUROSURGERY , cilt.113, sa.1, ss.11-13, 2011 (SCI-Expanded)

32. Treatment of Dementia Associated with Parkinson's Disease

Emre M.

PARKINSON'S DISEASE: NON-MOTOR AND NON-DOPAMINERGIC FEATURES , ss.163-169, 2011 (SCI-Expanded)

33. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

Emre M., Tsolaki M., Bonuccelli U., Destee A., Tolosa E., Kutzelnigg A., et al.

LANCET NEUROLOGY , cilt.9, sa.10, ss.969-977, 2010 (SCI-Expanded)

34. Early-Onset L-dopa-Responsive Parkinsonism with Pyramidal Signs Due to ATP13A2, PLA2G6, FBXO7 and Spatacsin Mutations

Paisan-Ruiz C., Guevara R., Federoff M., Hanagasi H. A., Sina F., Elahi E., et al.

MOVEMENT DISORDERS , cilt.25, sa.12, ss.1791-1800, 2010 (SCI-Expanded)

35. Safety and Efficacy of Perampanel in Advanced Parkinson's Disease: A Randomized, Placebo-Controlled Study

Eggert K., Squillacote D., Barone P., Dodel R., Katzenschlager R., Emre M., et al.

MOVEMENT DISORDERS , cilt.25, sa.7, ss.896-905, 2010 (SCI-Expanded)

36. Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease

Emre M., Bernabei R., Blesa R., Bullock R., Cunha L., Daniels H., et al.

CNS NEUROSCIENCE & THERAPEUTICS , cilt.16, sa.4, ss.246-253, 2010 (SCI-Expanded)

37. Effects of Rivastigmine in Alzheimer's Disease Patients with and Without Hallucinations

Cummings J., Emre M., Aarsland D., Tekin S., Dronamraju N., Lane R.

JOURNAL OF ALZHEIMERS DISEASE , cilt.20, sa.1, ss.301-311, 2010 (SCI-Expanded)

38. Memantine: a new hope for treatment of Lewy body-related dementias?

Emre M.

LANCET NEUROLOGY , cilt.8, sa.7, ss.594-595, 2009 (SCI-Expanded)

39. Psychotic and Compulsive Symptoms in Parkinson's Disease

Verbaan D., van Rooden S. M., Visser M., Marinus J., Emre M., van Hilten J. J.

MOVEMENT DISORDERS , cilt.24, sa.5, ss.738-744, 2009 (SCI-Expanded)

40. BuChE-K and APOE epsilon 4 Allele Frequencies in Lewy Body Dementias, and Influence of Genotype and Hyperhomocysteinemia on Cognitive Decline

Lane R., He Y., Morris C., Leverenz J. B., Emre M., Ballard C.

MOVEMENT DISORDERS , cilt.24, sa.3, ss.392-400, 2009 (SCI-Expanded)

41. MITOCHONDRIAL PATHOLOGY IN MUSCLE OF A PATIENT WITH A NOVEL PARKIN MUTATION

Hanagasi H. A., Serdaroglu P., Ozansoy M., Basak N., Tasli H., Emre M.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.119, sa.10, ss.1572-1583, 2009 (SCI-Expanded)

42. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease

Emre M., Mecocci P., Stender K.

JOURNAL OF ALZHEIMERS DISEASE , cilt.14, sa.2, ss.193-199, 2008 (SCI-Expanded)

43. Parkinson's Disease Dementia: Definitions, Guidelines, and Research Perspectives in Diagnosis

Goetz C. G., Emre M., Dubois B.

ANNALS OF NEUROLOGY , cilt.64, sa.6, 2008 (SCI-Expanded)

44. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia - A retrospective analysis of a double-blind trial and an open-label extension

Oertel W., Poewe W., Wolters E., De Deyn P. P., Emre M., Kirsch C., et al.

DRUG SAFETY , cilt.31, sa.1, ss.79-94, 2008 (SCI-Expanded)

45. Diagnostic procedures for Parkinson's disease dementia: Recommendations from the Movement Disorder Society Task Force

Dubois B., Burn D., Goetz C., Aarsland D., Brown R. G., Broe G. A., et al.

MOVEMENT DISORDERS , cilt.22, sa.16, ss.2314-2324, 2007 (SCI-Expanded)

46. Subthreshold depression in patients with Parkinson's disease and dementia - clinical and demographic correlates

Ehrt U., Bronnick K., De Deyn P. P., Emre M., Tekin S., Lane R., et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY , cilt.22, sa.10, ss.980-985, 2007 (SCI-Expanded)

47. Clinical diagnostic criteria for dementia associated with Parkinson's disease

Emre M., Aarsland D., Brown R., Bum D. J., Duyckaerts C., Mizuno Y., et al.

MOVEMENT DISORDERS , cilt.22, sa.12, ss.1689-1707, 2007 (SCI-Expanded)

48. Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: Similarities and differences

Emre M., Cummings J. L., Lane R. M.

JOURNAL OF ALZHEIMERS DISEASE , cilt.11, sa.4, ss.509-519, 2007 (SCI-Expanded)

49. Association between vitamin D receptor gene polymorphism and Alzheimer's disease

Gezen-Ak D., Dursun E., Ertan T., Hanagasi H. A., Guervit H., Emre M., et al.

Tohoku Journal of Experimental Medicine , cilt.212, sa.3, ss.275-282, 2007 (SCI-Expanded)

50. Neurosyphilis presenting with status epilepticus

Gurses C., Kurtuncu M., Jirsch J., Yesilot N., Hanagasi H. A., Bebek N., et al.

EPILEPTIC DISORDERS , cilt.9, sa.1, ss.51-56, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

51. Clinical and magnetic resonance imaging findings of HIV-Negative patients with neurosyphilis

GÜRSES C., Bilgic B., TOPÇULAR B., TUNCER O. G., AKMAN-DEMIR G., HANAGASI H. A., et al.

Journal of Neurology , cilt.254, sa.3, ss.368-374, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

52. Smoking-responsive juvenile-onset parkinsonism

Hanagasi H. A., Lees A., Johnson J. O., Singleton A., Emre M.

MOVEMENT DISORDERS , cilt.22, sa.1, ss.115-118, 2007 (SCI-Expanded)

53. Characterizing clinical phenotypes - The Lewys in their life or the life of their Lewys?

Lippa C. F., Emre M.

NEUROLOGY , cilt.67, sa.11, ss.1910-1911, 2006 (SCI-Expanded)

54. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease

Burn D., Emre M., McKeith I., De Deyn P. P., Aarsland D., Hsu C., et al.

MOVEMENT DISORDERS , cilt.21, sa.11, ss.1899-1907, 2006 (SCI-Expanded)

55. Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's disease

Dogru-Abbasoglu S., INCEOGLU M., PARILDAR-KARPUZOGLU H., HANAGASI H. A., KARADAG B., GURVIT H., et al.

NEUROSCIENCE LETTERS , sa.3, ss.258-261, 2006 (SCI-Expanded)

56. Dementia: From basics to the clinical syndrome

Emre M.

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY , cilt.61, sa.3, ss.306, 2006 (SCI-Expanded)

57. Comparative analysis of event-related potentials during Go/NoGo and CPT: Decomposition of electrophysiological markers of response inhibition and sustained attention

KIRMIZI-ALSAN E., Bayraktaroglu Z., Gurvit H., Keskin Y. H., EMRE M., Demiralp T.

Brain Research , cilt.1104, sa.1, ss.114-128, 2006 (SCI-Expanded)

58. Changes in motor subtype and risk for incident dementia in Parkinson's disease

Alves G., Petter Larsen J., Emre M., Wentzel-Larsen T., Aarsland D.

MOVEMENT DISORDERS , cilt.21, sa.8, ss.1123-1130, 2006 (SCI-Expanded)

59. Rivastigmine in Parkinson's disease dementia - A viewpoint by Murat Emre

Emre M.

CNS DRUGS , cilt.20, sa.9, ss.748, 2006 (SCI-Expanded)

60. Late-Onset Presentation of Ornithine Transcarbamylase Deficiency in a 65-Year-Old Female Patient

ÇOBAN A., Gurses C., Hanagasi H., Aminpoor P., BAYKAL B., GÜRVİT İ. H., et al.

EPILEPSI , cilt.11, sa.1, ss.22-28, 2005 (ESCI)

61. Spinoserebellar ataksi tip-2’li bir Türk ailesinde klinik ve moleküler analiz

HANAĞASI H. A., Ersoy N., BİLGİÇ B., SAHIN H., Annesi G., GÜRVİT İ. H., et al.

Parkinson Hastalığı ve Hareket Bozuklukları Dergisi , cilt.1, sa.1, ss.39-44, 2000 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 11

1. The Comparison of Gait and Balance Parameters According To The Findings of Cognitive Impairment, Falling and Freezing of Gait I Patients With Parkinson Disease

ERSÖZ HÜSEYİNSİNOĞLU B., ZİREK E., TÜFEKÇİOĞLU Z., BİLGİÇ B., HANAĞASI H. A., EMRE M.

Neurorehabilitation and Neural Repair, Maastricht, Hollanda, 22 Mayıs - 24 Eylül 2017, ss.87, (Tam Metin Bildiri)

2. Parkinson Hastalarında Yürüme ve Denge PArametrelerinin Kognisyon, Düşme ve Donma Bulgularına Göre Karşılaştırılması

ERSÖZ HÜSEYİNSİNOĞLU B., ZİREK E., TÜFEKÇİOĞLU Z., BİLGİÇ B., HANAĞASI H. A., EMRE M.

52. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 25 Kasım - 01 Aralık 2016, ss.310, (Tam Metin Bildiri)

3. An fMRI investigation of the neural correlates underlying football fanaticism

Makar Ç. C., KURT E., BİLGİÇ B., Ulaşoğlu Yıldız Ç., BÜYÜKGÖK D., EMRE M.

14. Ulusal Sinirbilim Kongresi, Ankara, Türkiye, 26 - 29 Mayıs 2016, ss.69-70, (Tam Metin Bildiri)

4. DEMENTIA IN PARKINSON'S DISEASE

Emre M.

6th International Conference on Alzheimers Disease and Related Disorders in the Middle East, İstanbul, Türkiye, 25 - 27 Ekim 2013, cilt.35, ss.716, (Özet Bildiri)

5. Effects of memantine on memory and language functions in Alzheimer's disease

Emre M.

12th Congress of the European-Federation-of-Neurological-Societies, Madrid, İspanya, 23 - 26 Ağustos 2008, cilt.15, ss.414, (Özet Bildiri)

6. Clinical features and treatment of dementia associated with Parkinson's disease

Emre M.

7th International Conference on Progress in Alzheimers and Parkinsons Disease, Sorrento, İtalya, 9 - 13 Mart 2005, cilt.57, ss.1-7, (Tam Metin Bildiri)

7. Vitamin D receptor, Presenilin 1 and interleukin 1 alpha gene SNPs and late-onset Alzheimer’s disease

DURSUN E., GEZEN AK D., Uysal Ö., ERTAN T., Bilgiç B., GÜRVİT İ. H., et al.

10th International Conference on Alzheimer’s Disease and Related Disorders, İspanya, cilt.2, ss.197, (Özet Bildiri)

8. SNPs at the ligand binding site of the vitamin D receptor gene and Alzheimer’s disease.

GEZEN AK D., DURSUN E., ERTAN T., HANAĞASI H. A., Gürvit H., Emre M., et al.

10th International Conference on Alzheimer’s Disease and Related Disorders,, İspanya, cilt.2, sa.3, ss.195-0, (Tam Metin Bildiri)

9. Polymorphisms at the Ligand Binding Sites of Vitamin D Receptor Gene and Alzheimer’s Disease

GEZEN AK D., DURSUN E., ERTAN T., HANAĞASI H. A., Gürvit H., Emre M., et al.

21st International Conference of Alzheimer’s Disease International, Türkiye, ss.50, (Tam Metin Bildiri)

10. Interleukin 1 Alpha Gene 5’ Regulatory Region Polymorphism in Alzheimer's Disease.

DURSUN E., GEZEN AK D., ERTAN T., Bilgiç B., Gürvit H., Emre M., et al.

European Human Genetics Conference 2005, Çek Cumhuriyeti, cilt.13, sa.1, ss.338, (Tam Metin Bildiri)

11. Interleukin1? Gene C(-889)T Polymorphism in Late-onset

GEZEN AK D., DURSUN E., ERTAN T., Bilgiç B., Gürvit H., Emre M., et al.

Alzheimer's Disease. 9th International Conference on Alzheimer’s Disease and Related Disorders, Philadelphia USA, Amerika Birleşik Devletleri, cilt.25, ss.504, (Tam Metin Bildiri)

Kitaplar 3

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

5341

H-İndeks (WoS)

Atıf (Scopus)

5763

H-İndeks (Scopus)

Atıf (Scholar)

516

H-İndeks (Scholar)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Açık Erişim